More than 12 billion coronavirus vaccine doses have been administered. There are, however, alternatives.
Stoffels will succeed CEO and co-founder Onno van de Stolpe, following his planned retirement.
Stocks stemmed their bleeding Monday after a rough start to the day.
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.
| Website: | www.jnj.com |
| Email: | invest@surgeenergy.ca |
| Main Phone: | +1 732 524-0400 |
| Address: | One Johnson and Johnson Plaza |
| Address 2: | Suite 2100 |
| State: | NJ |
| City / Town: | New Brunswick |
| Country: | US |
| Postal Code: | 08933 |
| Exchange: | NYE |
| CEO: | Alex Gorsky |
| Employees: | 136400 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
More than 12 billion coronavirus vaccine doses have been administered. There are, however, alternatives.
Stoffels will succeed CEO and co-founder Onno van de Stolpe, following his planned retirement.
Stocks stemmed their bleeding Monday after a rough start to the day.
“Today’s actions demonstrate our commitment to public health in proactively fighting against the COVID-19 pandemic,” said acting FDA commissioner Janet Woodcock, MD.
Once again, investors are asked to parse the difference between legal and ethical.
The Sacklers would be removed from ownership and would contribute $4.5 billion, but they would be shielded from any future lawsuits over opioids.
J&J said that trial participants who received a booster shot had a “nine-fold” increase of virus-fighting antibodies compared to what was observed four weeks after the initial dose.
The cities join New York in this measure designed to contain the fast-spreading Delta variant of the coronavirus.
Company leaders called it a matter of safety and cited “incredibly compelling” evidence of the effectiveness of the vaccines.
Sources say the FDA has set an unofficial deadline of Labor Day to render a decision.
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
